Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katharina Kilian

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 16, 2023
BAP1-inaktivierter melanozytärer Tumor: ein Fallbericht: BAP1 inactivated melanocytic tumor: a case reportUgur Sahin, André Barghorn, Katharina Kilian
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 22, 2023
BAP1 inactivated melanocytic tumor: a case reportUgur Sahin, André Barghorn, Katharina Kilian
Journal of Dentistry|May 21, 2026
Volume, Precision and Trueness of Additively Manufactured Inlay RestorationsAndreas Magnus Geyer, Sarah Katharina Kilian, David Kiramira, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 8, 2013
Rosacea - S1 guidelineMarkus Reinholz, Julia K Tietze, Katharina Kilian, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 25, 2013
Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha-2b in metastatic melanoma (phase II DeCOG trial)Annette Degen, Michael Weichenthal, Selma Ugurel, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 16, 2023
BAP1-inaktivierter melanozytärer Tumor: ein Fallbericht: BAP1 inactivated melanocytic tumor: a case reportUgur Sahin, André Barghorn, Katharina Kilian
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 22, 2023
BAP1 inactivated melanocytic tumor: a case reportUgur Sahin, André Barghorn, Katharina Kilian
Journal of Dentistry|May 21, 2026
Volume, Precision and Trueness of Additively Manufactured Inlay RestorationsAndreas Magnus Geyer, Sarah Katharina Kilian, David Kiramira, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 8, 2013
Rosacea - S1 guidelineMarkus Reinholz, Julia K Tietze, Katharina Kilian, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 25, 2013
Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha-2b in metastatic melanoma (phase II DeCOG trial)Annette Degen, Michael Weichenthal, Selma Ugurel, et al.
Pageof 1